ArticleAnalytical and bioanalytical chemistry2025
Mass spectrometry-based spatiotemporal characterization of lipids in early focal cerebral ischemia.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Understanding spatial lipid alterations in the brain during the hyper-acute phase of acute ischemic stroke (AIS) is crucial for elucidating the underlying mechanisms of disease progression and therapeutic response. In this study, we employed an integrated approach combining matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) and pseudo-targeted lipidomics to characterize lipid changes in the mice brain after 1 h, 2 h, and 3 h of middle cerebral artery occlusion (MCAO). Remarkably, MALDI-MSI detected significant lipid alterations in ischemic brain regions as early as 1 h post-MCAO, preceding visible tissue infarction by 2,3,5-triphenyltetrazolium chloride (TTC) staining. Lipidomics analysis further revealed region-specific lipid alterations at this early time point, suggesting that lipid profiles may serve as more sensitive biomarkers of ischemic brain injury than conventional histopathological methods. Notably, both MSI and lipidomics analysis demonstrated consistent temporal progression of lipid changes. Significantly altered lipids exhibited a nearly identical increasing trend with prolonged ischemic duration, with the ischemic cortex showing the most pronounced lipid dysregulation. In conclusion, our findings demonstrate that MALDI-MSI coupled with lipidomics provides a comprehensive platform for mapping the dynamic lipid landscape in the ischemic brain during early AIS, with observed patterns well correlating with the expansion of tissue infarction.
Indexed as
Identifiers
40576762What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.